What AEON Biopharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 1 |
| Sells | 0 | 0 |
| Total trades | 1 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 14 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lynch Timothy P | 10% owner | Aug 19 | Open-market buy · P | +1,150,000 | $0.21 | +$243K | 6,500,000 |
| Fischer Jost | Director | Jun 17 | Grant / award · A | +222,684 | — | — | 489,469 |
| Carter Eric G | Director | Jun 17 | Grant / award · A | +222,684 | — | — | 258,705 |
| Palmisano Robert J | Director | Jun 17 | Grant / award · A | +222,684 | — | — | 258,705 |
| Forth Marc | Director | Jun 17 | Grant / award · A | +222,684 | — | — | 973,231 |
| Thunen Shelley B | Director | Jun 17 | Grant / award · A | +222,684 | — | — | 258,705 |
| Bencich John | CHIEF FINANCIAL OFFICER | Apr 02 | Grant / award · A | +754,717 | — | — | 754,717 |
| Wilson Alexander Blair | CLO, CSO, and Corp Secretary | Mar 04 | Grant / award · A | +1,316,872 | — | — | 2,183,005 |
| Oh Chad | CHIEF MEDICAL OFFICER | Mar 04 | Grant / award · A | +1,316,872 | — | — | 2,183,436 |
| Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | Mar 04 | Grant / award · A | +925,925 | — | — | 1,501,176 |
| Bancroft Robert E. | PRESIDENT & CEO | Feb 17 | Grant / award · A | +3,000,000 | — | — | 3,177,103 |
| Wilson Alexander Blair | CLO, CSO, and Corp Secretary | Feb 17 | Grant / award · A | +862,500 | — | — | 866,133 |
| Oh Chad | CHIEF MEDICAL OFFICER | Feb 17 | Grant / award · A | +862,500 | — | — | 866,564 |
| Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | Feb 17 | Grant / award · A | +575,000 | — | — | 575,251 |
| Fischer Jost | Director | May 21 | Open-market buy · P | +60,000 | $0.49 | +$29.3K | 266,785 |
| Fischer Jost | Director | May 20 | Open-market buy · P | +60,000 | $0.51 | +$30.4K | 206,785 |
| Fischer Jost | Director | May 19 | Open-market buy · P | +50,000 | $0.50 | +$24.9K | 146,785 |
| Bancroft Robert E. | President & CEO | May 14 | Grant / award · A | +177,103 | — | — | 177,103 |
| Thunen Shelley B | Director | Aug 31 | Grant / award · A | +36,021 | — | — | 36,021 |
| Carter Eric G | Director | Aug 31 | Grant / award · A | +36,021 | — | — | 36,021 |
Loading...
